Amelia Melas is part of the Faber team helping various drug development clients with a range of contracting matters related to their R&D activities. Prior to joining Faber, she worked in-house at two companies (a large insurance provider and a health provider) and assisted both with matters related to healthcare regulation. This experience has provided her with firsthand knowledge of the regulatory space and the legal and business challenges facing healthcare companies. While at Boston University School of Law, Amelia was a Managing Editor for the American Journal of Law & Medicine, one of the country’s leading health law journals, where she has also published a paper.